93 related articles for article (PubMed ID: 3071058)
1. Prevention by a stable prostacyclin analogue, 7-oxoprostaglandin I2 of the platelet loss during experimental cardiopulmonary bypass.
Juhász-Nagy S; Kékesi V; Sótonyi P; Moravcsik G; Kovács G
Acta Chir Hung; 1988; 29(3):251-61. PubMed ID: 3071058
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
[TBL] [Abstract][Full Text] [Related]
3. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
4. Platelet loss during experimental cardiopulmonary bypass and its prevention with prostacyclin.
Plachetka JR; Salomon NW; Larson DF; Copeland JG
Ann Thorac Surg; 1980 Jul; 30(1):58-63. PubMed ID: 6994666
[TBL] [Abstract][Full Text] [Related]
5. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
Addonizio VP; Fisher CA; Kappa JR; Ellison N
Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
[TBL] [Abstract][Full Text] [Related]
6. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
[TBL] [Abstract][Full Text] [Related]
8. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
Takeda H
Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
[TBL] [Abstract][Full Text] [Related]
9. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
Szekeres L; Krassói I; Pataricza J; Udvary E
Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
[TBL] [Abstract][Full Text] [Related]
10. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
Lichtenthal PR; Wade LD; Rossi EC
Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
[No Abstract] [Full Text] [Related]
12. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
Rådegran K; Arén C; Teger-Nilsson AC
J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
[TBL] [Abstract][Full Text] [Related]
15. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
16. [Effect of prostaglandin I2 derivative infusion during experimental cardiopulmonary bypass].
Matsukura H; Takeda H; Uzawa S; Sakai K; Kawakami T; Tanabe T
Nihon Kyobu Geka Gakkai Zasshi; 1983 Jun; 31(6):871-5. PubMed ID: 6352833
[No Abstract] [Full Text] [Related]
17. Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect--anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin.
von Heymann C; Hagemeyer E; Kastrup M; Ziemer S; Proquitté H; Konertz WF; Spies C
Pediatr Crit Care Med; 2006 Jul; 7(4):383-5. PubMed ID: 16738494
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
[TBL] [Abstract][Full Text] [Related]
19. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
[TBL] [Abstract][Full Text] [Related]
20. Application of a new prostaglandin I2 analogue (APS-306) on cardiopulmonary bypass.
Takahama T; Kanai F; Iizuka I; Hiraishi M; Yamazaki Z; Idezuki Y; Sudo K; Asano K; Morioka M; Kazama M
Trans Am Soc Artif Intern Organs; 1984; 30():44-8. PubMed ID: 6398549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
